DOGSTEM
Pioneers in the world in the use of umbilical cord as an active ingredient.
DogStem is the only licensed stem cell medicine.
DogStem has demonstrated superior efficacy compared to currently available treatments for canine osteoarthritis. This efficacy has been rigorously demonstrated using objective variables.
Additionally, 65% of owners say DogStem has significantly improved their dog's quality of life.
While currently available treatments focus on addressing the symptoms of osteoarthritis, DogStem, with its dual action, has a symptomatic effect by reducing pain and lameness, and modulates the progression of the disease by slowing its evolution, regenerating damaged cartilage, and acting on the hostile environment of the joint by "deactivating" inflammatory cascades.
In addition to being more effective than other available treatments, DogStem's effect is long-lasting. In clinical studies, 59% of patients experienced an effect lasting more than 6 months, and in half of those cases, the effect lasted over 12 months.
DogStem has proven to be safe both locally and systemically. While conventional treatments can have hepatic, digestive, and renal side effects, DogStem has no such adverse effects. For this reason, conventional treatments may be contraindicated for animals with pre-existing conditions or senior animals; however, DogStem has been administered to animals of all ages from one year old and of all health conditions without any systemic side effects.
While currently available treatments for pain and lameness associated with osteoarthritis require daily, weekly, or monthly administration, a single dose of DogStem provides a sustained effect, eliminating the need for frequent repeat doses. Furthermore, safety trials have demonstrated that DogStem is safe with repeated dosing.